Explore the 2024 Event Program

Thank you to our speakers, sponsors, and delegates who joined us in 2024 for the summit! 

If you are interested in the 2025 event, please get in touch at info@hansonwade.com

The 2024 Program Allowed Attendees to:

View the full speaker faculty and in-depth session details offering actionable solutions for their in vivo editing challenges

Learn how to access the best available rates and discounts to gain the most value from their attendance

Explore the unparalleled networking opportunities with in vivo leaders like Capstan Therapeutics, Editas Medicine, and more!

Get a glimpse into the immersive workshops that provided real-world solutions to 2024 in vivo editing challenges, including a lack of regulatory clarity and animal model selection

3rd In Vivo Cell Engineering & Gene Editing Summit - Full Agenda

Having issues downloading? Click here to request a copy of the agenda!

Hoping for specific content on the 2025 agenda?

"This series leads the race on placing in vivo gene medicines, and particularly in vivo CAR therapy, on the map"
Adrian Bot, Chief Scientific Officer, Capstan Therapeutics

Companies From Our Expert Speaker Faculty Included: